Aphria Inc reported CAD216.99M in Current Liabilities for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Ani Pharmaceuticals ANIP:US $ 89.45M 6.69M
Aurora Cannabis Inc ACB:CN 116.38M 15.33M
Canopy Growth Corp WEED:CN C$ 256.13M 28.2M
Corcept Therapeutics CORT:US $ 45.4M 4.8M
Cronos Group Inc CRON:CN 200.6M 102.04M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Lannett LCI:US $ 90.47M 6.66M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Pacira Pharmaceuticals PCRX:US $ 228.69M 3.39M
Supernus Pharmaceuticals SUPN:US $ 283.45M 42.64M